CEO Ford’s $2M Buy‑The‑Dip Boost Signals Abbott’s Potential Upswing
Abbott CEO’s $2 M buy‑the‑dip in a 28% slump shows confidence that diagnostics, vascular and nutrition lines can revive stock value after earnings miss.
2 minutes to read
Abbott Laboratories